Clinical Significance of Noninvasive Intracranial Pressure Monitoring in Moderate Brain Injury

黄达,陈梦,刘胜,蔡志明
DOI: https://doi.org/10.3969/j.issn.1671-7171.2014.11.024
2014-01-01
Abstract:Objective] To explore clinical application value of noninvasive intracranial pressure monitoring in moderate brain injury .[Methods]A total of 29 patients with moderate brain injury receiving expectant treatment in our hospital were randomly divided into 2 groups .According to the condition after trauma ,the monitoring group( n=15) received intracranial pressure and mean arterial blood pressure monitoring per 6h in order to understand the change of cerebral perfusion pressure(CPP) ,and then were given mannitol with CPP at 60~80mmHg once per 6~8h according to intracranial pressure monitoring state .The dynamic change of intracranial pressure in monitoring group was recorded .Control group( n =14) received conventional therapy i .e .intravenous injection with 20 mannitol 125~250mL once per 6~8h ,and stopped mannitol according to clinical symptoms or was given CT or further therapy according to clinical symptoms and pupil change .[Results]In monitoring group ,the average hospitalization day was 12 .6 ± 2 .10d ,and the duration and dose of mannitol were 7 .6 ± 1 .59d and 5713 .3 ± 1291 .75ml ,respectively .In control group ,the average hospitalization day was 18 .71 ± 1 .33d ,and the duration and dose of mannitol were 15 ± 1 .22d and 9653 .57 ± 1371 .75 mL ,respectively .There were signifi‐cantly differences between two groups( P<0 .05) .The moderate disability rate in monitoring group and control group were 6 .67%and 28 .57% respectively ,and there was significant difference between two groups .No turnover below severe disability in two groups was found .Abnormal renal function rate in monitoring group and control group was 13 .30% and 21 .40% respectively ,but there was no significant difference between two groups( P>0 .05) .[Conclusion]Noninvasive intracranial pressure monitoring is helpful to guide physicians use mannitol reasonably .CPP at 60~80mmHg maintained by noninvasive intracranial pressure monitoring can improve the prognosis and shorten hospital stay of patients .Persistent noninvasive monitoring for patients with moderate brain injury is of vital sig‐nificance in guiding the treatment ,improving the prognosis and increasing the efficacy .Therefore ,it has high clinical value .
What problem does this paper attempt to address?